CAR T-cells in Non-Hodgkin Lymphoma, A Hopeful Option
CAR T-cell therapy is a promising treatment for patients who have relapsed (the disease came back after treatment) or refractory (the disease did not respond to intial thereapy) non-Hodgkin lymphoma.